Clearmind Medicine Inc.
CMND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001892500
No open-market purchases or sales by Clearmind Medicine Inc. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $107.9K in total; no superinvestor holds it.
Holders of 5% or more of CMND
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Clearmind Medicine Inc., largest stake first. The change is against the holder's previous filing.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
16 Schedule 13D and 13G filings on Clearmind Medicine Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 12, 202610:46 AM ET | Iroquois Capital Management, LLCand 2 others | 13G/A | 9.99%346.7K shares | – | Jun 30, 2026 | SEC |
| May 15, 20264:15 PM ET | L.I.A. Pure Capital Ltd | 13G/A | 0.00%0 shares | −5.00 ppfrom 5.00%Below 5% | Mar 31, 2026 | SEC |
| May 15, 20264:15 PM ET | Capitalink Ltd. | 13G/A | 0.00%0 shares | −5.00 ppfrom 5.00%Below 5% | Mar 31, 2026 | SEC |
| Mar 16, 202611:12 AM ET | L.I.A. Pure Capital Ltd | 13G/A | 5.00%108.7K shares | −4.97 ppfrom 9.97% | Feb 9, 2026 | SEC |
| Mar 16, 202610:17 AM ET | Capitalink Ltd. | 13G/A | 5.00%107.9K shares | −4.97 ppfrom 9.97% | Feb 9, 2026 | SEC |
| Mar 9, 20264:30 PM ET | Daniel Nissim | 13G/A | 0.00%0 shares | −9.99 ppfrom 9.99%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 202610:48 AM ET | Iroquois Capital Management, LLCand 2 others | 13G/A | 9.99%166.5K shares | +0.05 ppfrom 9.94% | Dec 31, 2025 | SEC |
| Dec 10, 20254:15 PM ET | L.I.A. Pure Capital Ltd | 13G/A | 9.97%5.98M shares | −0.02 ppfrom 9.99% | Dec 3, 2025 | SEC |
| Dec 10, 20254:15 PM ET | Capitalink Ltd. | 13G/A | 9.97%5.98M shares | −0.02 ppfrom 9.99% | Dec 3, 2025 | SEC |
| Dec 1, 20254:15 PM ET | Capitalink Ltd. | 13G | 9.99%3.31M shares | New | Nov 19, 2025 | SEC |
| Dec 1, 20254:15 PM ET | L.I.A. Pure Capital Ltd | 13G | 9.99%3.31M shares | New | Nov 19, 2025 | SEC |
| Nov 28, 20254:15 PM ET | Daniel Nissim | 13G | 9.99%3.31M shares | New | Nov 19, 2025 | SEC |
| Nov 18, 20256:50 AM ET | Iroquois Capital Management, LLCand 2 others | 13G/A | 9.94%603.5K shares | +3.70 ppfrom 6.24% | Sep 30, 2025 | SEC |
| Jul 3, 20251:46 PM ET | AdvisorShares Trust | 13G/A | 4.83%205.9K shares | –Below 5% | Jun 30, 2025 | SEC |
| Feb 14, 20251:27 PM ET | Iroquois Capital Management, LLCand 2 others | 13G/A | 6.24%451.7K shares | – | Dec 31, 2024 | SEC |
| Dec 18, 20237:23 AM ET | Polatov Eli | 13G/A | 0.00%0 shares | –Below 5% | Dec 5, 2023 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Clearmind Medicine Inc. shares.
No Form 144 notices for Clearmind Medicine Inc. are on file.